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ABSTRACT: The complex [Rh(µ-Cl)(IPr)(η2-coe)]2 {IPr = 1,3-bis-(2,6-diisopropylphenyl)imidazol-2-carbene, coe = cis-
cyclooctene} efficiently catalyzes the coupling of alkynes and N-vinylpyrazole via C-H activation, leading to Markovnikov-
selective butadienylpyrazole derivatives under mild conditions. A straightforward approach to cross-conjugated acyclic trienes is 
also operative through a one-pot alkyne dimerization-hydrovinylation tandem reaction. The proposed mechanism involves C-H 
activation of vinylpyrazole directed by nitrogen coordination to the metallic center. Subsequent alkyne coordination, insertion and 
reductive elimination steps lead to the coupling products. Several key intermediates participating in the catalytic cycle have been 
detected and characterized including a κ–N, η2–C=C coordinated vinylpyrazole complex and a RhIII-hydride-alkenyl species result-
ing from the C-H activation of the vinylpyrazole 
INTRODUCTION 
Transition-metal catalyzed C-C bond formation via C-H ac-
tivation has been revealed as a very powerful, selective and 
atom-economical tool of increasing importance in current 
organic synthesis.1 This impressive success would have not 
been possible without an in-depth study of the factors that 
control the reactivity of catalytic intermediate species, whose 
understanding is essential in order to rationally design active 
and selective catalysts.2 Particularly, rhodium catalysts play a 
relevant role in this area due to their functional group toler-
ance, substrate scope, and its high level of activity and selec-
tivity for a wide range of synthetic transformations.3 In partic-
ular, the Murai reaction have allowed for the construction of 
intricate conjugated structures from the coupling of aromatic 
or vinylic heteroatom-substituted substrates with carbon-
carbon unsaturated partners such as olefins or alkynes (Figure 
1).1a,4 Although oxygen-containing moieties have been widely 
used as directing groups (DG), a range of nitrogen-based func-
tional groups such as amine,5 imine,6 pyridine,7 oxime,8 oxazo-
line,9 nitrile,10 or others,11 have also been investigated in order 
to reduce the energy barrier for C-H activation. Regarding the 
nature of the C-H bond, aromatic protons have been common-
ly involved in this process, but functionalization of vinyl C-H 
is more problematic due to competitive polymerization or 
Michael-type addition reactions.3c Moreover, electron-rich 
olefins are much less reactive and, actually, the activation of 
α-heteroatom alkenes is limited to enamides,12 ketoenamines,13 
or cyclic compounds.14 It is thus of paramount importance to 
broaden the applicability of C-H bond activation synthetic 
strategy to that challenging substrates. 
 
Figure 1. Hydrovinylation of alkynes mediated by Rh-NHC 
catalysts. 
Pyrazole-based derivatives have attracted an increased in-
terest in recent years owing to their widespread applications in 
medicine, agriculture, material science or catalysis.15 Classical 
synthetic approaches consists in the assembly of the pyrazole 
core via dicarbonyl-hydrazine cyclocondensations, or dipolar 
cycloadditions, albeit more recently, cross-coupling substitu-
tion into the pyrazole framework has emerged as an alternative 
 procedure.16 In spite of this plethora of preparative methods, 
the development of new selective and atom economical pro-
cesses still remains an important target. In this context, pyra-
zole coordination directs the functionalization of aromatic or 
aliphatic C-H bonds,17 but activation of vinylic protons in the 
electron rich N-vinyl derivatives has not been yet reported to 
date. Reactivity studies on vinylpyrazole derivatives are 
scarce18 and mainly restricted to Diels-Alder19 or polymeriza-
tion reactions.20 
A practical approach to overcome the challenging C-H acti-
vation of N-vinylpyrazole is based on catalyst design by using 
powerful electron-donating ligand such as an N-heterocyclic 
carbene (NHC) in order to facilitate the C-H activation pro-
cess.21 Moreover, the steric bulk of these ligands has a signifi-
cant influence on the selectivity control over the catalytic 
outcome, which is also an important issue.22 In this context, 
we have recently disclosed RhI-NHC catalysts for alkyne 
hydrothiolation,23a,d hydroalkynylation23c,e or hydrovinyla-
tion23b with high selectivity to Markonikov-type addition 
products. Now, we present herein an efficient and unprece-
dented Markovnikov-regioselective N-vinylpyrazol hydrovi-
nylation of terminal or internal alkynes, and 1,3-disubstituted 
enynes catalyzed by a rhodium-NHC catalyst. The mechanism 
of this transformation has been investigated by means of stoi-
chiometric low temperature NMR experiments. In addition, 
the successful isolation and characterization of key intermedi-
ate species has allowed us to propose a plausible catalytic 
cycle. 
RESULTS AND DISCUSSION 
Catalytic Hydrovinylation of Alkynes with Vinylpyra-
zole. Recently our research group has demonstrated that dinu-
clear compounds of type [Rh(µ-Cl)(NHC)(η2-olefin)]2,24 {1a; 
NHC ≡ 1,3-bis-(2,6-diisopropylphenyl)imidazol-2-carbene 
(IPr); olefin ≡ cis-cyclooctene (coe)} are valuable starting 
materials for the preparation of mononuclear complexes of 
type RhCl(NHC)(η2-olefin)(L) by simple bridge-cleavage with 
a nucleophilic ligand.23 Particularly, treatment of 1a with 2-
vinylpyridine lead to the isolation of RhCl(IPr){κ–N,η2-
CH2=CH(C5H4N)}, which is an efficient catalyst for the syn-
thesis of 2-butadienylpyridines via C-C coupling with terminal 
and internal alkynes without apparent dimerization or 
polymerization.23b Moreover, subsequent thermal 6π-
electrocyclization of internal-substituted 2-butadienylpyridines 
give access to 4H-quinolizines. The efficiency demonstrated 
by these RhI-NHC complexes in the alkyne hydrovinylation 
reaction prompt us to apply this methodology to the more 
challenging C-H activation of the electron-rich olefin of N-
vinylpyrazole derivatives.  
As a preliminary test, 1-vinylpyrazole (vpz, 2a) and 1-
hexyne (3a) were chosen as model substrates (Scheme 1, 
Table 1). After 24 h at 40 ºC, the formation of two hydrovi-
nylation products was observed with an overall conversion of 
37%. Both products arise from syn addition with a clear pref-
erence for the Z/geminal (gem) isomer 1-{3-methylene-1(Z)-
heptenyl}pyrazole (4a) versus the Z/E 1-{1(Z),3(E)-
octadienyl}pyrazole (5a) derivative (83:17). Interestingly, the 
catalytic activity was improved significantly at 70 ºC. After 2 
h, a 95% conversion was attained while maintaining the selec-
tivity (Table 1, entry 2). Notably, neither the dimerization nor 
cyclotrimerization of the alkyne was observed.23c,e This pro-
cess represents a new straightforward method for butadi-
enylpyrazole derivatives which could find potential applica-
tions as building blocks for further functionalization via cy-
clization, addition or oxidation reactions among other trans-
formations.25 
The presence of a NHC ligand seems to be essential for a 
high efficient catalytic coupling, as is reflected from the low 
conversion or total inactivity observed when the Wilkinson 
catalyst RhCl(PPh3)3 (1b) or the dinuclear complex [Rh(µ-
Cl)(η2-coe)2]2 (1c) were used as catalysts (Table 1, entries 3 
and 4). Moreover, mononuclear complex RhCl(IPr)(η4-cod) 
(1d) (cod = 1,4-cyclooctadiene) was also much less active that 
1a (Table 1, entry 5). The strong coordination of the diolefin 
compared to the labile coe ligands may account for the very 
different catalytic activity.23a,b In early works we discovered 
that addition of pyridine (py) to catalyst 1a dramatically im-
proves the regioselectivity to Markonikov-type additions to 
unsaturated compounds.23a,c,e In sharp contrast, the presence of 
pyridine is detrimental for the hydrovinylation process (table 
1, entry 6), resulting in a decrease of the catalytic activity with 
concomitant formation of the alkyne dimerization product 7-
methylene-5-undecyne (43%). 
Scheme 1. Catalyst Precursors for the Coupling Reaction 
of 1-Vinylpyrazole with 1-Hexyne and Products Formed 
Thereof 
 
Table 1. Screening of Catalyst and Conditions for the 
Coupling of 1-Vinylpyrazole with 1-Hexynea 
entry catalyst T(ºC) t(h) conversion(%)b 4a 5a 
 1 1a 40 24 37 83 17 
 2 1a 70   2 95 84 16 
 3 1b 70 24 11 54 46 
 4 1c 70 24 -- -- -- 
 5 1d 70 24   8 82 18 
 6 1a+py 70   2 70c 47d 10d 
aReaction conditions: 0.01 mmol of 1 in C6D6 (0.5 mL), 0.2 mmol of 1-
vinylpyrazole and 1-hexyne. bFormation of Z/gem + Z/E butadienylpyra-
zole relative to 1-vinylpyrazole. cCalculated from 1-hexyne consump-
tion. dFormation of 43% of 7-methylene-5-undecyne.  
The scope of catalyst 1a was evaluated for various aliphatic 
and aromatic alkynes using 2a and 3,5-dimethyl-1-
vinylpyrazole (vpzMe, 2b) (Table 2). High conversion was 
attained under relative mild conditions (70 ºC) and short times 
(2-8 h) with a clear bias to Z/gem-butadienylpyrazoles 4a-i 
(see Supporting Information). As a general trend, 2a reacted 
 faster than 2b, but in contrast, an outstanding Markonikov 
selectivity was attained for the substituted vinylpyrazole, 
reaching up to 98% for benzylacetylene and 1-octyne (Table 2, 
entries 1-3 vs 5-7). No isomerization was observed for aliphat-
ic alkynes, either for the internal double bond of 4 to form 
E/gem-butadienylpyrazoles (6), or for the exo-methylene to 
give rise to an internal diene (Scheme 2). However, aromatic 
alkynes behave differently. The formation of the coupling 
products of phenylacetylene with 2a (37%) competed with the 
dimerization (26%) and cyclotrimerization (39%) of the al-
kyne. These side reactions were significantly reduced when 
using the substituted pyrazole 2b (see Supporting Infor-
mation). Moreover, the initially formed Z/gem-
butadienylpyrazoles 4d,h-i isomerized to E/gem dienes 6 to 
the point that only 6h-i could be recovered from the chroma-
tographic column (Table 2, entries 8 and 9) (Scheme 2). The 
presence of an electron-donating group in the aromatic ring 
slightly increased the catalytic activity whereas an electron-
withdrawing group results in an increase of alkyne cyclotri-
merization byproducts (Table 2, entries 8-10). 
Table 2. Hydrovinylation of Terminal Alkynes with 1-
Vinylpyrazolesa 
entry 2  alkyne t(h)  conv (%)b  4 5 6 yield (%)c 
 1   2a    2 95 84 16 -- 80 (4a) 
 2   2a    3 94 83 17 -- 75 (4b) 
 3   2a    3 98 90 10 -- 67 (4c) 
 4   2a    2 98d 24e -- 13e -- 
 5   2b    8 92 95   5 -- 85 (4e) 
 6   2b    8 90 98   2 -- 81 (4f) 
 7   2b    5 96 98   2 -- 78 (4g) 
 8   2b    5 99d 56e -- 28e 53f (6h) 
 9   2b    4 98d 55e -- 35e 62f (6i) 
 10   2b    1 98d 29e -- 14e --  
aReaction conditions: 0.01 mmol of 1a in C6D6 (0.5 mL), 0.2 mmol of 1-
vinylpyrazole derivative and terminal alkyne at 70 oC. bFormation of 
Z/gem + Z/E butadienylpyrazole relative to 1-vinylpyrazole. cIsolated 
yield. dCalculated from alkyne consumption. eFormation of alkyne 
dimerization and cyclotrimerization products. fE/gem butadienylpyrazole 
derivatives were isolated. 
Scheme 2. Isomerization of Butadienylpyrazol Derivatives 
 
Hydrovinylation with 1-vinylpyrazoles is also operative for 
terminal diynes. Under the optimized reaction conditions 1,7-
octadiyne was completely transformed in 3-5 h. A mixture of 
monohydrovinylated Z/gem product, 1-{3-methylene-1(Z),8-
nonenynyl}pyrazole (7) (25-27%), and the doubly coupled 
derivatives bis-Z/gem, 1,1'-{3,8-dimethylene-1(Z),9(Z)-
decadiene-1,10-diyl}bis(pyrazole) (8) (61-70%), and Z/gem, 
Z/E 1,1'-{3-methylene-1(Z),8(E),10(Z)-undecatriene-1,10-
diyl}bis(pyrazole) (9) (2-14%), were obtained (Scheme 3). In 
both cases, the major component having two exo-methylene 
substituents, 8a and 8b, were isolated by chromatographic 
column in 58 and 67% yield, respectively, after chromato-
graphic purification. Noteworthy, the selectivity trend to Mar-
konikov-addition products is maintained with the di-
substituted pyrazole 2b being slightly more selective than 2a.  
Scheme 3. Coupling Reaction of 1-Vinylpyrazole Deriva-
tives and 1,7-Dioctyne 
 
The scope of the hydrovinylation reaction was extended to a 
series of internal alkynes (Scheme 4 and Table 3). In all cases 
1-Z-butadienylpyrazoles (10) were formed as main products 
accompanied with a small amount of the 1-E-stereoisomer 11. 
The increment of isomerized products with regard to terminal 
alkynes is probably due to prolonged reaction times. Aryl 
derivatives reacted faster than aliphatic alkynes and, as it was 
observed before, substituted pyrazole 2b was transformed 
slower than 2a. Notably, the unsymmetrical 1-phenyl-1-
propyne showed different behavior depending on the vinylpy-
razole derivative. A mixture of regioisomers was isolated from 
reaction with 2a, whereas 1,3-dimethyl-1-{3-phenyl,1(Z),3(Z)-
pentadienyl}pyrazole was obtained in 76% isolated yield from 
the reaction with substituted pyrazole 2b (Table 3, entries 3 
and 6).  
Table 3. Hydrovinylation of Internal Alkynesa 
entry 2 alkyne t(h) conv % 10 11 yield (%)b 
 1  2a  14 87 96   4 75 (10a) 
  2  2a    1 99 95   5 77 (10b) 
 3  2a    1 92 53c/47d   1 78 (10c+c’)e 
 4  2b  24f 98 92   8 83 (10d) 
 5  2b  23 94 81 19 64 (10e) 
 6  2b  24 99 82c/16d   2 76 (10f) 
a Reaction conditions: 0.01 mmol of 1a in C6D6 (0.5 mL), 0.2 mmol of 
1-vinylpyrazole derivative, 2a or 2b, and internal alkyne at 70 ºC. 
bIsolated yield. c3-phenyl-4-methylbutadienylpyrazole. d3-methyl-4-
phenylbutadienylpyrazol. eIsolated as a mixture of regioisomers. f80 ºC. 
Scheme 4. Coupling Reaction Between 1-Vinylpyrazoles 
and Internal Alkynes 
 
Recently, our research group has disclosed that the catalytic 
system 1a/py is very efficient for the regioselective Markoni-
kov-type head-to-tail dimerization of terminal alkynes to 
enynes.23c,e Thus, we envisaged the possibility of further trans-
form these enynes by reaction with vinylpyrazoles in one-pot. 
Gratifyingly, this goal has been achieved (Scheme 5). Initially, 
the catalytic system 1a + 10 equiv py triggered the dimeriza-
tion of phenylacetylene to 1,3-diphenyl-3,1-butenyne (12a) 
after 6 h at 40 ºC. Then, pyridine was removed from the reac-
tion media under vacuum, otherwise the subsequent hydrovi-
nylation would not proceed efficiently. Refill of the NMR tube 
with C6D6 and the corresponding 1-vinylpyrazole resulting in 
the selective formation of the cross-conjugated 1-{3-
benzylidene-4-phenyl-1(Z),4-pentadienyl}pyrazole deriva-
tives, 13a-b, after heating at 70 ºC for 12 h. The identity of 
this branched acyclic trienes was unambiguously established 
from 1H-13C HMBC and 1H-1H NOE NMR experiments. This 
methodology is also applicable for coupling of 1-
vinylpyrazoles with the enyne obtained from the dimerization 
of 1-hexyne. Remarkably for these cases, the triene products, 
13c-d, undergo an intramolecular thermal Alder-ene transfor-
mation to give 1-(3-{1(E)-pentenyl}-4-methyl-1(Z),3(Z)-
octadienyl)pyrazole derivatives, 14c-d, that were isolated and 
fully characterized. These examples demonstrate the potential 
and versatility of this catalytic transformation. 
Scheme 5. One-Pot Alkyne Dimerization/Hydrovinylation 
 
Isolation of Intermediate Species Relevant for the Cata-
lytic Mechanism. To gain information on the mechanism of 
this catalytic transformation, we have study the reactivity of 
catalytic precursor 1a with 1-vinylpyrazole derivatives under 
stoichiometric conditions. Treatment of complex 1a with 2a in 
toluene at 40 oC for 30 min resulted in an equilibrium between 
the dinuclear species [Rh(µ-Cl)(IPr)(ƞ2-vpz)]2 (15), resulting 
from olefin exchange, and the mononuclear complex 
RhCl(IPr)(κ–N,η2-vpz) (16), arising from the cleavage of the 
chloride bridges in 15 by coordination of the pyrazole moiety, 
in a 60:40 ratio (Scheme 6). The 1H and 13C{1H} NMR spectra 
showed two sets of signals corresponding to coordinated olefin 
and carbene in both complexes. In particular, the two doublets 
observed in the 13C{1H} NMR spectra at δ ≈ 65 and 26 ppm 
(JC-Rh = 17-19 Hz) are diagnostic of the coordination of the 
olefin moiety of the N-vinylpirazole ligands (See Experi-
mental Section). 
Scheme 6. Preparation of RhI vinylpyrazole complexes 
  
In contrast to that observed for vinylpyrazole, treatment of 
1a with 3,5-dimethyl-1-vinylpyrazole in toluene at room tem-
perature led to the isolation of complex RhCl(IPr)(κ–N,η2-
vpzMe) (17) as a yellow solid in 68% yield. The clean for-
mation of 17 is in agreement with the higher basicity of 2b 
compared with 2a. The chelate coordination of N-
vinylpyrazole ligands in complexes 16 and 17 is labile and 
donor ligands produce N-decoordination. Thus, when the 
reactions were conducted in the presence of pyridine complex-
es RhCl(IPr)(η2-vpz)(py) (18) and RhCl(IPr)(η2-vpzMe)(py) 
(19) were obtained as result of coordination of the amine with 
vinylpyrazole ligands bound in an η2–olefin fashion. At room 
temperature complex 19 is in equilibrium with 17, however, 
the equilibrium is completely shifted to the opened-
vinylpyrazole compound 19 at -40 ºC, indicating the higher 
coordination ability of 2b with regard to 2a. 
The solid state structures of 17 and 19 were determined by 
single crystal X-ray diffraction studies (Figures 2 and 3). To 
the best of our knowledge they are the first structurally charac-
terized metal complexes containing a κ–N,η2–C=C and a η2–
C=C coordinated vinylpyrazole ligand, respectively. The 
asymmetric unit of 17 contains two crystallographically inde-
pendent pseudo mirror–image molecules featuring different 
configuration at the –CH= vinylic atom. Both molecules dis-
play very similar angles and bond distances therefore only the 
molecule with R configuration will be discussed herein (Figure 
2). The metal center presents a distorted square planar geome-
try with coordination sites occupied by the chlorido ligand, the 
carbene carbon atom and the vinylpyrazole coordinated in a κ–
N,η2–C=C fashion with the nitrogen atom trans to the carbene 
ligand {C(1)–Rh(1)–N(51), 169.98(13) deg}. The Rh(1)–C(1) 
length {1.954(4) Å} falls within the shortest reported for other 
rhodium-NHC single bond distances.21d,23,24 The vinylpyrazole 
moiety displays a short bite angle (71.9 deg), which causes a 
severely distorted arrangement of the pyrazole ring with pitch 
(θ, 24.4 deg) and yaw angles (ψ, 38.4 deg)26 significantly 
different from the expected values close to 0 deg (See Sup-
porting Information for further details). Additionally, it is 
worth mentioning that a CH/π interaction was observed be-
tween the vinyl hydrogen H(58) and the C(11)–C(16) phenyl 
ring of IPr. As a matter of fact, the vinyl hydrogen H(58) stays 
at 2.47 Å from the centroid of the phenyl ring and at 2.44 Å 
from the phenyl plane, and consequently the angle between the 
vector joining H(58) with the centroid and the perpendicular to 
the ring is 8.9 deg. Accordingly, the interatomic distances 
between H(58) and the carbon atoms of the phenyl ring are in 
the range 2.67-2.99 Å, shorter than the sum of the van der 
Waals radii (3.05 Å).27 
 
Figure 2. ORTEP view of one of the independent molecules 
of 17 (ellipsoids at 50% of probability). Wireframe view of 
iso–propyl groups is adopted for clarity. Selected bond dis-
tances (Å) and angles (deg): Rh(1)–C(1), 1.954(4); Rh(1)–
Cl(1), 2.3483(10); Rh(1)–C(58), 2.067(4); Rh(1)–C(59), 
2.105(4); C(58)–C(59), 1.399(5); Rh(1)–N(51), 2.186(3); 
C(1)–Rh(1)–Cl(1), 89.13(10); C(1)–Rh(1)–N(51), 169.98(13). 
The molecular structure of 19 is shown in Figure 3 along 
with selected bond distances and angles. The metal center 
features a slightly distorted square planar coordination con-
taining the chloro atom Cl(1), the carbene carbon atom C(1), 
and the nitrogen atom N(61) of bonded pyridine in an almost 
planar arrangement with nitrogen in the trans position with 
respect to the carbene ligand {C(1)–Rh(1)–N(61), 169.96(10) 
deg}. The coordination sphere is completed by the vinylpyra-
zole featuring a η2–C=C coordination mode. The distances 
around the rhodium atom are similar to those of 17. 
  
Figure 3. ORTEP view of 19 (ellipsoids at 50% of probabil-
ity). Wireframe view of iso–propyl groups is adopted for clari-
ty. Selected bond distances (Å) and angles (deg): Rh(1)–C(1), 
1.991(3); Rh(1)–Cl(1), 2.3757(7); Rh(1)–N(61), 2.107(2); 
Rh(1)–C(58), 2.080(3); Rh(1)–C(59), 2.105(3); C(58)–C(59), 
1.402(4); C(1)–Rh(1)–Cl(1), 92.91(8); C(1)–Rh(1)–N(61), 
169.96(10). 
The NMR spectra of 17-19 are in agreement with the struc-
ture observed in the solid state. The 1H NMR spectra show the 
expected set of resonances for the η2-olefin moiety. It is no-
ticeable the shielding of the vinyl =CH- resonance of 17 (δ 
3.55 ppm) compared to that of 18 and 19 (≈ 5.5 ppm) which 
suggest that the CH/π interaction observed in the solid state is 
maintained in solution. More interesting is the 15N-1H HMBC 
spectra of 17-19. The coordinated nitrogen atom of the N-
vinylpyrazole moiety in 17 appeared at δ 235.6 ppm, whereas 
the resonance corresponding to the uncoordinated nitrogen 
atom was downfield-shifted to δ 304.7 (18) and 316.0 ppm 
(19). The pyridine ligand in both complexes was observed 
upfield-shifted to δ 266.8 (18) and 263.7 ppm (19) with regard 
to free pyridine (δ 318.3 ppm).23c 
The formation of complexes 15-17 should take place in the 
first step of the catalytic process. Coordination on vinylpyra-
zole by the nitrogen atom may favor the C-H activation of the 
olefin. Thus, when the reaction of 1a with vinylpyrazole was 
carried out at 120 oC for 20 min the presence of the hydride-
alkenyl complex RhClH[κ–N,κ–C{CH=CH(pz)}](IPr) (20) 
was observed (Scheme 7). The 1H NMR spectrum of 20 
showed a doublet at δ -30.31 ppm with JH-Rh = 38.2 Hz as-
signed to the hydride ligand. In addition, the 13C{1H} NMR 
spectrum displayed a doublet at δ 185.0 ppm (JC-Rh = 38.9 Hz) 
corresponding to the Rh-carbene carbon atom and, more inter-
estingly, another doublet at δ 137.4 ppm (JC-Rh = 12.8 Hz) that 
can be ascribed to a rhodium-alkenyl moiety. In addition to 
complex 20, a small amount of a new complex was observed. 
Heating the reaction at 120º for 2 hours led to the enrichment 
of that species which allowed its characterization as 
RhCl(IPr){κ–Na,ƞ2-CH(pz)b=CH(CH2)2(pz)a} (21) Interesting-
ly, the (Z)-1,1'-(1-butene-1,4-diyl)bis(pyrazole) ligand of 21 
results from self-hydrovinylation of the 1-vinylpyrazole. The 
1H NMR spectrum of 21 showed a doublet of doublets at δ 
5.29 ppm and a multiplet at 3.43 ppm, corresponding to the 
coordinated olefin, in addition to the signals ascribed to four 
aliphatic protons at δ 3.92, 3.12, 2.45, and 1.79 ppm. The 
13C{1H} spectrum was also in agreement with the proposed 
structure and shows one doublet at δ 183.4 ppm (JC-Rh = 54.4 
Hz), corresponding to the Rh-IPr carbon atom, and two dou-
blets at 63.9 (JC-Rh = 18.0 Hz) and 44.7 ppm (JC-Rh = 15.8 Hz) 
for the η2-coordinated olefin. The 15N-1H HMBC spectrum 
also supports the proposed structure for 21. The coordinated 
nitrogen atom of a pyrazole moiety is upfield shifted to δ 
250.3 ppm compared to the uncoordinated nitrogen atom of 
the free heterocyclic fragment that is observed at 306.8 ppm. 
The nitrogen atoms attached to the connector in both cycles 
were observed at similar chemical shifts (219.6 and 209.5 
ppm). Alternatively, complex 21 could be obtained from the 
reaction of 1a with 2a (molar ratio 1:4), after heating at 120 oC 
for 2 h through the intermediate complex RhCl(IPr)(κ–
N,vpz)(ƞ2-vpz) (22) bearing two 1-vinylpirazole ligands hav-
ing different coordination modes. The more noticeable NMR 
features of 22 are the signal corresponding to free and coordi-
nated olefinic moiety. The –CH= proton of the uncoordinated 
double bond appears at δ 8.29 ppm in the 1H NMR spectrum, 
which correlates with a singlet in the 13C{1H} NMR at δ 134.4 
ppm, whereas these resonances for the coordinated olefin were 
observed at 5.43 ppm and 66.5 ppm (JC-Rh = 17.7 Hz). 
Scheme 7. Rhodium-IPr Intermediates of the Catalytic 
Process 
 
In view of the detected intermediate species a plausible 
mechanism for the alkyne hydrovinylation is depicted in 
Scheme 8. The first step consists in the substitution of η2-coe 
ligand by 1-vinylpyrazole, which is supported by the identifi-
cation of compounds 16-17. Subsequent C-H oxidative addi-
tion of the olefin affords a RhIII–hydride–alkenyl species 20. 
Then, alkyne coordinates and subsequent insertion into the 
Rh-H bond lead to a bis-alkenyl complex that undergoes re-
ductive elimination to give the coupled organic products. 
More likely, the origin of Markovnikov selectivity arises from 
the preferred 2,1-hydrometallation driven by the steric hin-
drance between the bulky NHC ligand and the alkyne as pre-
viously observed for hydrothiolation or hydroalkynylation 
transformations using a related catalytic system. The distorted 
chelate coordination arrangement of the vinylpyrazole facili-
tates the exchange between the coupling organic products and 
a new molecule of the substrate regenerating the active species 
of the catalytic cycle. The activation of Csp-H proton of the 
alkyne can compete with the C-H activation of the vinylpyra-
zole, particularly for the more acidic aromatic alkynes, thus 
the dimerization process may be operative under this circum-
stances (See Table 2, entries 4,8-10). In the absence of the 
 alkyne the double bond of the vinylpyrazole would insert into 
the Rh-H moiety leading to the formation of 21.  
Scheme 8. Proposed Catalytic Cycle for the Hydrovinyla-
tion of alkynes  
 
C O N CL U S IO N  
Complex [Rh(µ-Cl)(IPr)(η2-coe)]2 efficiently catalyzes the 
hydrovinylation of alkynes via C-H activation of N-
vinylpyrazoles leading to Markovnikov-selective butadi-
enylpyrazole derivatives under mild conditions. The presence 
of the carbene ligand in the rhodium catalyst seems to be 
essential for the catalytic coupling in order to afford the chal-
lenging C-H activation of the electron-rich nitrogenated olefin. 
It has been observed that 1-vinylpyrazol react faster than 3,5-
dimethyl-1-vinylpyrazole but with slightly lower selectivity. 
Aliphatic terminal alkynes are preferentially hydrovinylated 
without dimerization, cyclotrimerization or polymerization of 
the alkyne. In addition, no isomerization of the exo-methylene 
group leading to an internal diene has been observed. The 
synthetic utility of the catalytic process is reflected in the 
preparation of cross-conjugated acyclic trienes through a one-
pot alkyne dimerization-hydrovinylation tandem reaction.  
The proposed mechanism involves C-H activation of vi-
nylpyrazole directed by nitrogen coordination to the metallic 
center. Subsequent alkyne coordination, insertion and reduc-
tive elimination steps leads to the coupling products. Several 
intermediates participating in the catalytic cycle have been 
detected and characterized. The first step consists in the coor-
dination of the vinylpyrazole in a κ–N,η2–C=C fashion. The 
assistance of the nitrogen atom facilitates the vinyl C-H acti-
vation process leading to RhIII-hydride-alkenyl intermediate 
species that has been detected by NMR. Further work on the 
application of this catalytic system for the functionalization of 
pyrazole and other nitrogenated heterocycles is currently being 
developed in our laboratories.   
E XP E R IM E N TA L  S E CT IO N  
General Considerations. All reactions were carried out 
with rigorous exclusion of air using Schlenk-tube techniques. 
Alkynes were purchased from commercial sources and were 
used as received, except for phenylacetylene that was distilled 
under argon and stored over molecular sieves. 1,3-
disubstituted enynes23c and 1-vinylpyrazole28 derivatives were 
synthetized following the procedure described in the literature. 
Organic solvents were dried by standard procedures and dis-
tilled under argon prior to use or obtained oxygen- and water-
free from a Solvent Purification System (Innovative Technol-
ogies). The organometallic precursor [Rh(µ-Cl)(IPr)(η2-coe)]2 
(1a) was prepared as previously described in the literature.24 
1H, 13C{1H} and HMBC 1H-15N spectra were recorded either 
on a Bruker ARX 300 MHz or a Bruker Avance 400 MHz 
instruments. Chemical shifts (expressed in parts per million) 
are referenced to residual solvent peaks (1H, 13C{1H}) or liquid 
NH3 (15N). Coupling constants, J, are given in Hz. Spectral 
assignments were achieved by combination of 1H-1H COSY, 
13C{1H}-APT and 1H-13C HSQC/HMBC experiments. C, H, 
and N analyses were carried out in a Perkin-Elmer 2400 
CHNS/O analyzer. GC-MS analysis were recorder on an Ag-
ilent 5973 mass selective detector interfaced to an Agilent 
6890 series gas chromatograph system, using a HP-5MS 5% 
phenyl methyl siloxane column (30 m x 250 mm with a 0.25 
mm film thickness). 
Standard Catalytic Conditions. A NMR tube was charged 
with 0.01 mmol of catalyst, 0.2 mmol of vinylpyrazole and 0.2 
mmol of the alkyne, in 0.5 mL of C6D6 under an argon atmos-
phere. The solution was heated at 70 ºC and monitored in a 
NMR spectrometer. The conversion was quantified by the 
integration of the 1H NMR signals of 1-vinylpyrazole deriva-
tive and the products. After reaction completion the solvent 
was removed under vacuum and the residue purified by chro-
matography on silica gel using 99:1 hexane:diethyl ether as 
eluent to give the compounds. 
In situ formation of [Rh(µ-Cl)(IPr)(ƞ2-vpz)]2 and 
RhCl(IPr)(κ–N,η2-vpz) (15, 16): A solution of 1a (30 mg, 0.023 
mmol) in toluene-d8 (0.5 mL, NMR tube) was treated with 1-
vinylpyrazole (5 µL, 0.047 mmol) and was heated at 40 ºC for 30 
min. A 60:40 mixture of 15:16 was observed. Data for 15: 1H 
NMR (400 MHz, toluene-d8, 298 K): δ 7.36 (d, JH-H = 1.6, 2H, H3-
pz), 7.3-7.1 (12H, HPh), 6.59 and 6.56 (both m, 4H, =CHN), 5.71 
(m, 2H, CH=CH2), 5.61 (dd, JH-H = 2.5, 1.6, 2H, H4-pz), 5.45 (d, 
JH-H = 2.5, 2H, H5-pz), 4.73, 4.18, 3.92, and 2.38 (all br, 8H, 
CHMeIPr), 2.68 (ddd, JH-H = 10.2, 2.2, JH-Rh = 2.2, 2H, CH=CH2), 
1.97 (d, JH-H = 7.4, 2H, CH=CH2), 1.38, 1.66, 1.57, 1.50, 1.11, 
1.06, 1.04, and 0.93 (all d, JH-H = 6.5, 48H, CHMeIPr). 13C{1H}-
APT NMR (100 MHz, toluene-d8, 298 K): δ 180.9 (d, JC-Rh = 
55.3, Rh-CIPr), 151.6, 150.2, 148.9, and 149.8 (all s, Cq-IPr), 138.5 
(s, C3-pz), 136.8 and 136.7 (both s, CqN), 131.4 (s, C5-pz), 129-122 
(CPh), 123.7 and 123.5 (both s, =CHN), 104.5 (s, C4-pz), 68.3 (d, 
JC-Rh = 19.4, CH=CH2), 29-22 (CHMeIPr), 27.2 (d, JC-Rh = 16.9, 
CH=CH2). Data for 16: 1H NMR (400 MHz, toluene-d8, 298 K): 
δ 7.3-7.1 (br, 6H, HPh), 6.95 (d, JH-H = 1.0, 1H, H3-pz), 6.63 (s, 4H, 
=CHN), 6.42 (d, JH-H = 2.1, 1H, H5-pz), 5.75 (dd, JH-H = 2.1, 1.0, 
1H, H4-pz), 4.41 (dd, JH-H = 10.2, 8.5, 1H, CH=CH2), 4.03 (ddd, 
JH-H = 10.2, 2.2, JH-Rh = 2.2, 1H, CH=CH2), 2.83 and 2.73 (both 
sept, JH-H = 6.8, 4H, CHMeIPr), 1.58 (overlapped, CH=CH2), 1.48, 
1.17, 1.16, and 1.12 (all d, JH-H = 6.8, 24H, CHMeIPr). 13C{1H}-
APT NMR (100 MHz, toluene-d8, 298 K): δ 181.2 (d, JC-Rh = 
62.3, Rh-CIPr), 145.9 and 145.5 (both s, Cq-IPr), 137.9 (s, CqN), 
137.4 (s, C3-pz), 129-123 (CPh), 128.0 (s, C5-pz), 122.9 (s, =CHN), 
104.6 (s, C4-pz), 63.0 (d, JC-Rh = 17.7, CH=CH2), 29-22 (CHMeIPr), 
26.1 (overlapped, CH=CH2). 
 Preparation of RhCl(IPr)(κ–N,η2-vpzMe) (17). A yellow solu-
tion of 1a (100 mg, 0.078 mmol) in 10 mL of toluene was treated 
with 3,5-dimethyl-1-vinylpyrazole (19 µL, 0.157 mmol) and 
stirred for 1 h at room temperature. After filtration through Celite 
the solvent was evaporated to dryness. Addition of hexane in-
duced the precipitation of a yellow solid, which was washed with 
hexane (3 x 4 mL) and dried in vacuo. Yield: 70 mg (68%). Anal. 
Calcd. for C34H46N4ClRh: C, 62.91; H, 7.14; N, 8.63. Found: C, 
63.13; H, 7.35; N, 8.41. 1H NMR (300 MHz, C6D6, 298 K): δ 7.38 
(t, JH-H = 7.6, 2H, Hp-Ph), 7.31 (dd, JH-H = 7.8, 7.6, 4H, Hm-Ph), 6.67 
(s, 2H, =CHN), 5.20 (s, 1H, H4-pz), 4.08 and 3.05 (both br, 4H, 
CHMeIPr), 3.55 (dd, JH-H = 7.5, 7.2, 1H, CH=CH2), 3.13 (d, JH-H = 
7.2, 1H, CH=CH2), 2.23 (dd, JH-H = 7.5, JH-Rh = 2.2, 1H, 
CH=CH2), 2.17 (s, 3H, Me3-pz), 1.72, 1.21, 1.20, and 1.16 (all d, 
JH-H = 7.0, 24H, CHMeIPr), 1.63 (s, 3H, Me5-pz). 13C{1H}-APT 
NMR (75 MHz, C6D6, 298 K): δ 181.5 (d, JC-Rh = 61.0, Rh-CIPr), 
150.7 (s, C3-pz), 147.2 and 146.2 (both s, Cq-IPr), 137.0 (s, CqN), 
136.0 (s, C5-pz), 129.5 (s, Cp-Ph), 123.9 and 123.6 (both s, Cm-Ph), 
123.5 (s, =CHN), 103.8 (s, C4-pz), 60.9 (d, JC-Rh = 14.6, CH=CH2), 
34.7 (d, JC-Rh = 14.5, CH=CH2), 29.0 and 28.7 (both s, CHMeIPr), 
26.6, 25.5, 23.4, and 22.9 (all s, CHMeIPr), 12.5 (s, Me3-pz), 8.4 (s, 
Me5-pz). 15N-HMBC (40 MHz, C6D6, 298K): δ 235.6 (N2-pz), 231.2 
(N1-pz), 191.5 (NIPr). 
Preparation of RhCl(IPr)(ƞ2-vpz)(py) (18). A solution of 1a (30 
mg, 0.023 mmol) in 10 mL of toluene was treated with 1-
vinylpyrazole (5 µL, 0.047 mmol) and pyridine (18 µL, 0.25 
mmol) and stirred for 1 h at room temperature. After filtration 
through Celite the solvent was evaporated to dryness. Addition of 
hexane induced the precipitation of a yellow solid, which was 
washed with hexane (3 x 4 mL) and dried in vacuo. Yield: 70 mg 
(63%). Anal. Calcd. for C37H47N5ClRh: C, 63.47; H, 6.76; N, 
10.00. Found: C, 63.23; H, 7.10; N, 9.74. 1H NMR (400 MHz, 
toluene-d8, 243 K): δ 7.96 (d, JH-H = 4.8, 2H, Ho-py), 7.5-6.9 (m, 
6H, HPh), 6.95 (d, JH-H = 2.2, 1H, H5-pz), 6.75 and 6.74 (both m, 
=CHN), 6.60 (d, JH-H = 1.9, 1H, H3-pz), 6.50 (t, JH-H = 7.7, 1H, Hp-
py), 6.05 (dd, JH-H = 7.7, 4.8, 2H, Hm-py), 5.88 (dd, JH-H = 2.2, 1.9, 
1H, H4-pz), 5.52 (dd, JH-H = 9.6, 6.4, 1H, CH=CH2), 4.75, 3.78, 
3.06, and 2.31 (all br, 4H, CHMeIPr), 3.06 (d, JH-H = 9.6, 1H, 
CH=CH2), 2.51 (dd, JH-H = 6.4, JH-Rh = 2.3, 1H, CH=CH2), 1.97, 
1.67, 1.66, 1.23, 1.14, 1.13, 1.05, and 1.04 (all d, JH-H = 6.6, 24H, 
CHMeIPr). 13C{1H}-APT NMR (100 MHz, toluene-d8, 298 K): δ 
182.6 (d, JC-Rh = 53.5, Rh-CIPr), 151.5 (s, Co-py), 146.0, 145.8, 
145.6, and 145.5 (all s, Cq-IPr), 135.1 and 134.4 (both s, CqN), 
136.6 (s, C3-pz), 133.9 (s, Cp-py), 128.7 (s, C5-pz), 124.9, 124.5, 
124.4, 123.6, 123.4, and 122.4 (all s, CPh), 123.4 and 123.1 (both 
s, =CHN), 122.1 (s, Cm-py), 105.5 (s, C4-pz), 66.1 (d, JC-Rh = 18.7, 
CH=CH2), 28.3 (d, JC-Rh = 17.2, CH=CH2), 28.9, 28.8, 28.7, 28.6 
(all s, CHMeIPr), 26.8, 26.3, 26.2, 26.0, 25.7, 23.5, 22.4, and 22.3 
(all s, CHMeIPr). 15N-HMBC (40 MHz, toluene-d8, 298 K): δ 
304.7 (N2-pz), 266.8 (Npy), 223.9 (N1-pz), 191.3 and 193.8 (NIPr). 
In situ formation of RhCl(IPr)(ƞ2-vpzMe)(py) (19). A solution 
of 1a (30 mg, 0.023 mmol) in toluene-d8 (0.5 mL, NMR tube) at 
room temperature was treated with 3,5-dimethyl-1-vinylpyrazole 
(5 µL, 0.041 mmol) and pyridine (18 µL, 0.25 mmol). After 10 
min NMR spectra were recorded at low temperature. 1H NMR 
(400 MHz, toluene-d8, 243 K): δ 8.03 (d, JH-H = 4.8, 2H, Ho-py), 
7.3-7.1 (m, 6H, HPh), 6.70 and 6.40 (both s, =CHN), 6.42 (t, JH-H 
= 7.0, 1H, Hp-py), 6.05 (dd, JH-H = 7.0, 4.8, 2H, Hm-py), 5.58 (dd, 
JH-H = 9.7, 5.6, 1H, CH=CH2), 5.29 (s, 1H, H4-pz), 4.60, 3.42, 3.28, 
and 2.45 (all br, 4H, CHMeIPr), 3.20 (d, JH-H = 9.7, 1H, CH=CH2), 
2.15 (d, JH-H = 5.6, 1H, CH=CH2), 1.88 (s, 3H, Me3-pz), 1.80, 1.73, 
1.62, 1.18, 1.15, 1.13, 1.12, and 0.92 (d, JH-H = 6.2, 24H, 
CHMeIPr), 1.42 (s, 3H, Me5-pz). 13C{1H}-APT NMR (100 MHz, 
toluene-d8, 243 K): δ 181.9 (d, JC-Rh = 53.4, Rh-CIPr), 151.5 (s, Co-
py), 148.4, 148.0, 146.1, and 145.5 (all s, Cq-IPr), 144.5 (s, C3-pz), 
138.9 (s, C5-pz), 137.3 and 136.9 (both s, CqN), 133.8 (s, Cp-py), 
124.3, 123.7, 122.9, and 121.9 (all s, CPh), 123.5 and 123.3 (both 
s, =CHN), 121.9 (s, Cm-py), 106.6 (s, C4-pz), 65.6 (d, JC-Rh = 18.5, 
CH=CH2), 28.1 (d, JC-Rh = 15.6, CH=CH2), 28.9, 28.8, 28.7, and 
28.5 (all s, CHMeIPr), 29.4, 29.2, 27.1, 26.5, 26.4, 25.7, 23.3, and 
23.1 (all s, CHMeIPr), 13.2 (s, Me3-pz), 11.0 (s, Me5-pz). 15N-
HMBC (40 MHz, toluene-d8, 243 K): δ 316.0 (N2-pz), 263.7 (Npy), 
213.9 (N1-pz), 193.1 and 188.0 (NIPr). 
In situ formation of RhClH[κ–N,κ–C{CH=CH(pz)}](IPr) 
(20). A solution of 1a (30 mg, 0.023 mmol) in toluene-d8 (0.5 
mL, NMR tube) was treated with 1-vinylpyrazole (5 µL, 0.047 
mmol) and was heated at 120 ºC for 20 min. 1H NMR (400 MHz, 
toluene-d8, 298 K): δ 7.48 (d, JH-H = 2.0, 1H, H3-pz), 7.3-7.1 (br, 
6H, HPh), 7.03 (m, 1H, RhCH=CH), 6.85 (JH-H = 7.8, 1H, 
RhCH=CH), 6.55 (s, 2H, =CHN ), 6.45 (d, JH-H = 2.2, 1H, H5-pz), 
5.44 (dd, JH-H = 2.2, 2.0, 1H, H4-pz), 3.29 and 3.08 (both br, 4H, 
CHMeIPr), 1.15, 1.11, 1.03, and 1.02 (all br, 24H, CHMeIPr), -
30.31 (d, JH-Rh = 38.2, 1H, Rh-H). 13C{1H}-APT NMR (100 MHz, 
toluene-d8, 298 K): δ 185.0 (d, JC-Rh = 38.9, Rh-CIPr), 146.7 and 
146.3 (both s, Cq-IPr), 141.7 (s, C3-pz), 137.4 (d, JC-Rh = 12.8, 
RhCH=CH), 135.9 (s, CqN), 129-122 (CPh), 124.7 (s, C5-pz), 122.5 
(s, =CHN), 118.5 (d, JH-H = 3.0, RhCH=CH), 105.3 (s, C4-pz), 28.2 
and 27.8 (both s, CHMeIPr), 26.2, 25.9, 22.8, and 22.7 (all s, 
CHMeIPr).  
Preparation of RhCl(IPr){κ–Na,η2-CH(pz)b=CH(CH2)2(pz)a} 
(21). A solution of 1a (30 mg, 0.023 mmol) in C6D6 (0.5 mL, 
NMR tube) was treated with 1-vinylpyrazole (10 µL, 0.094 
mmol) and was heated at 120 oC for 2 h. 1H NMR (300 MHz, 
toluene-d8, 298 K): δ 7.55 (d, JH-H = 1.8, 1H, H3-pza), 7.5-7.2 (m, 
6H, Ph), 7.24 (d, JH-H = 2.2, 1H, H5-pzb), 7.21 (d, JH-H = 2.2, 1H, 
H3-pzb), 6.75 (m, 2H, =CHN), 6.25 (d, JH-H = 2.1, 1H, H5-pza), 5.92 
(dd, JH-H = 2.2, 2.2, 1H, H4-pzb), 5.53 (dd, JH-H = 2.1, 1.8, 1H, H4-
pza), 5.29 (dd, JH-H = 6.7, JH-Rh = 3.3, 1H, NCH=CH), 4.59, 4.32, 
2.59, and 2.58 (all br, 4H, CHMeIPr), 3.92 (dd JH-H = 12.8, 12.8, 
1H, CH2N), 3.43 (m, 1H, CH=CHCH2), 3.12 (d, JH-H = 12.8, 1H, 
CH2N), 2.45 and 1.79 (both m, 2H, CH=CHCH2), 1.99, 1.71, 
1.51, 1.26, 1.24, 1.20, 1.09, and 1.00, (all d, JH-H = 6.4, 24H, 
CHMeIPr). 13C{1H}-APT NMR (75 MHz, toluene-d8, 298 K): δ 
183.4 (d, JC-Rh = 54.4, Rh-CIPr), 148.8, 148.7, 145.8, and 145.7 (all 
s, Cq-IPr), 141.9 (s, C3-pza), 137.7 (s, C3-pzb), 137.1 and 137.0 (both 
s, CqN), 132.2 (s, C5-pzb), 130.0 and 129.6 (both s, Cp-Ph), 128.5 (s, 
C5-pza), 125.0 and 124.0 (both s, =CHN), 124.5, 124.3, 123.2, and 
122.6 (all s, Cm-Ph), 104.8 (s, C4-pza), 103.2 (s, C4-pzb), 63.9 (d, JC-Rh 
= 18.0, NCH=CHCH2), 49.8 (d, JC-Rh = 2.7, CH2N), 44.7 (d, JC-Rh 
= 15.8, NCH=CHCH2), 25.5 (s, CH=CHCH2), 29.2, 28.8, 28.7, 
and 28.6 (all s, CHMeIPr), 26.8, 26.7, 26.6, 26.2, 23.4, 23.2, 22.3, 
and 21.6 (all s, CHMeIPr). 15N-HMBC (40 MHz, toluene-d8, 298 
K): 306.8 (N2b-pz), 250.3 (N2a-pz), 219.6 (N1b-pz), 209.5 (N1a-pz), 
193.8 and 189.0 (NIPr). 
In situ formation of RhCl(IPr)(κ-N,vpz)(ƞ2-vpz) (22). A solu-
tion of 1a (30 mg, 0.023 mmol) in toluene-d8 (0.5 mL, NMR tube) 
was treated with 1-vinylpyrazole (10 µL, 0.094 mmol) at room 
temperature. The complex was formed immediately. 1H NMR 
(400 MHz, toluene-d8, 298 K): δ 8.29 (dd, JH-H = 15.6, 9.0, 1H, 
CH=CH2-a), 7.42 and 7.35 (both t, JH-H = 7.8, 2H, Hp-Ph), 7.21 and 
7.06 (both d, JH-H = 7.8, 2H, Hm-Ph), 7.02 (br, 1H, H5-pza), 6.86 (br, 
1H, H5-pzb), 6.68 (br, 1H, H3-pza), 6.59 (br, 2H, =CHN), 6.07 (br, 
1H, H4-pza), 5.73 (br, 1H, H3-pzb), 5.44 (br, 1H, H4-pzb), 5.43 (br, 
1H, CH=CH2-b), 4.72 (d, JH-H = 15.6, 1H, CH=CH2-a), 4.60, 3.81, 
2.70, and 2.14 (all sept JH-H = 6.5, 4H, CHMeIPr), 4.40 (d, JH-H = 
9.0, 1H, CH=CH2-a), 2.82 (d, JH-H = 10.0, 1H, CH=CH2-b), 2.26 
(d, JH-H = 3.8, 1H, CH=CH2-b), 1.87, 1.56, 1.44, 1.18, 1.09, 1.07, 
0.99, and 0.95 (all d, JH-H = 6.5, 24H, CHMeIPr). 13C{1H}-APT 
NMR (100 MHz, toluene-d8, 298 K): δ 182.7 (d, JC-Rh = 54.8, Rh-
CIPr), 148.8, 148.6, 145.9, and 145.8 (all s, Cq-IPr), 140.9 (s, C3-pzb), 
136.8 and 136.7 (both s, CqN), 134.4 (s, CH=CH2-a), 133.0 (s, C3-
 pzb), 130.1, 129.6, 125.2, 124.6, 122.6, and 122.4 (all s, CPh), 
126.2 (s, C5-pzb), 124.0 (s, C5-pzb), 123.6 and 123.5 (both s, 
=CHN), 107.0 (s, C4-pzb), 106.4 (s, C4-pza), 98.1 (s, CH=CH2-a), 
65.8 (d, JC-Rh = 17.7, CH=CH2-b), 28.8, 28.7, 28.4, and 28.3 (all s, 
CHMeIPr), 27.2 (d, JC-Rh = 17.2, CH=CH2-b), 27.2, 26.5, 26.8, 
24.1, 22.9, 22.3, 22.2, and 22.1 (all s, CHMeIPr). 
Molecular Structure Determination for complexes 17 and 19. 
Single crystals for the X-ray diffraction study of 17 and 19 were 
grown by slow diffusion of hexane into a concentrated solution of 
17 in toluene and 19 in THF. Intensity data were collected at 100 
K (15) and 110 K (21) on a Bruker SMART CCD area detector 
diffractometer equipped with graphite monochromated Mo-Kα 
radiation (λ = 0.71073 Å) using narrow frames (0.3˚ in ω). Data 
were corrected for Lorentz and polarization effects, and a sem-
iempirical absorption correction was applied using SADABS 
program.29 The structures were solved by Patterson method using 
SHELXS–9730 included in the APEX2 package and completed by 
successive difference Fourier syntheses. Refinements were carried 
out by full-matrix least-squares on F2 with SHELXL-2013 run-
ning under WinGX31 including isotropic and subsequent aniso-
tropic displacement parameters for all non-hydrogen atoms. The 
methyl hydrogen atoms were included in calculated positions and 
refined as riding atoms while the rest of hydrogen atoms were 
obtained from difference Fourier maps and refined as free iso-
tropic atoms.  
Crystal data for 17: C34H46ClN4Rh, M = 649.11, monoclinic, 
space group P21/c, yellow, 0.190 x 0.180 x 0.140 mm, a = 
24.481(4), b = 13.201(2), c = 20.184(3) Å, β = 93.847(2)º, V = 
6508.0(2) Å3, Z = 8, µ(MoKα) = 0.635 mm–1, Dcalc = 1.325 g cm–
3, Tmin = 0.786; Tmax = 0.915. 50774 reflections measured (2.44 ≤ 
θ ≤ 28.326º), 13323 independent reflections (Rint = 0.0577); num-
ber of data/restrains/parameters 13323/0/869. R1 = 0.0468 
(I>2σ(I)); 0.0719 (all data); wR(F2) = 0.0802 (I>2σ(I)); 0.0892 
(all data); S = 1.094 (all data). CCDC deposit number: 1012069. 
Crystal data for 19: C39H51ClN5Rh, M = 728.20, monoclinic, 
space group P21/n, yellow, 0.220 x 0.180 x 0.070 mm, a = 
15.5790(11), b = 13.8030(10), c = 18.6728(13) Å, β = 
112.173(1)º, V = 3718.4(5) Å3, Z = 4, µ(MoKα) = 0.564 mm–1, 
Dcalc = 1.301 g cm–3, Tmin = 0.812; Tmax = 0.961. 38427 reflections 
measured (1.888 ≤ θ ≤ 26.021º), 7310 independent reflections 
(Rint = 0.0584); number of data/restrains/parameters 7310/0/509. 
R1 = 0.0387 (I>2σ(I)); 0.0499 (all data); wR(F2) = 0.0700 
(I>2σ(I)); 0.0748 (all data); S = 1.077 (all data). CCDC deposit 
number: 1012070 
AS S OC IAT E D  C O N T E N T   
Experimental procedures, spectral data and scanned NMR spectra 
for all organic compounds; determination of pitch and yaw angles 
of 17 and ratio of cyclotrimerization and dimerization for aro-
matic alkynes (Table S1). This material is available free of charge 
via the Internet at http://pubs.acs.org.  
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